Paper37101392
Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution.
Xu R and 4 others. CPT Pharmacometrics Syst Pharmacol, 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution. Papers, record 37101392. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37101392
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Thiazoles | Major topic |
| Renal Insufficiency | Major topic |
| Adult | |
| Humans | |
| Pyridines | |
| Drug Interactions | |
| Anticoagulants | |
| Models, Biological | |
| Computer Simulation |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 38845389 | Correction to "Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution". | https://conductscience.org/library/papers/38845389 |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36002079 | The next frontier in ADME science: Predicting transporter-based drug disposition, tissue concentrations and drug-drug interactions in humans. | Pharmacol Ther | 2022 | https://conductscience.org/library/papers/36002079 | PubMed |
| 2 | 31506301 | Systematic Development and Verification of a Physiologically Based Pharmacokinetic Model of Rivaroxaban. | Drug Metab Dispos | 2019 | https://conductscience.org/library/papers/31506301 | PubMed |
| 3 | 27647273 | Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine. | J Pharmacokinet Pharmacodyn | 2016 | https://conductscience.org/library/papers/27647273 | PubMed |
| 4 | 25186833 | Population pharmacokinetics and dose-exposure proportionality of edoxaban in healthy volunteers. | Clin Drug Investig | 2014 | https://conductscience.org/library/papers/25186833 | PubMed |
| 5 | 35745692 | Drug-Drug Interactions of Direct Oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35745692 | PubMed |
| 6 | 27897269 | An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure. | Pharmacogenomics J | 2018 | https://conductscience.org/library/papers/27897269 | PubMed |
| 7 | 35579824 | Prediction of Drug-Drug Interactions After Esketamine Intranasal Administration Using a Physiologically Based Pharmacokinetic Model. | Clin Pharmacokinet | 2022 | https://conductscience.org/library/papers/35579824 | PubMed |
| 8 | 29728318 | Non-Vitamin K-Dependent Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With CKD: Pragmatic Considerations for the Clinician. | Am J Kidney Dis | 2018 | https://conductscience.org/library/papers/29728318 | PubMed |
| 9 | 32987693 | Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32987693 | PubMed |
| 10 | 31420941 | Expanded Physiologically-Based Pharmacokinetic Model of Rifampicin for Predicting Interactions With Drugs and an Endogenous Biomarker via Complex Mechanisms Including Organic Anion Transporting Polypeptide 1B Induction. | CPT Pharmacometrics Syst Pharmacol | 2019 | https://conductscience.org/library/papers/31420941 | PubMed |
| 11 | 20135207 | Model analysis of the concentration-dependent permeability of P-gp substrates. | Pharm Res | 2010 | https://conductscience.org/library/papers/20135207 | PubMed |
| 12 | 37101392 | Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution. | CPT Pharmacometrics Syst Pharmacol | 2023 | https://conductscience.org/library/papers/37101392 | PubMed |
| 13 | 33545293 | Quantitative analysis of an impact of P-glycoprotein on edoxaban's disposition using a human physiologically based pharmacokinetic (PBPK) model. | Int J Pharm | 2021 | https://conductscience.org/library/papers/33545293 | PubMed |
| 14 | 32504376 | Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice. | Drugs | 2020 | https://conductscience.org/library/papers/32504376 | PubMed |
| 15 | 28990182 | Effect of Chronic Kidney Disease on Nonrenal Elimination Pathways: A Systematic Assessment of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and OATP. | Clin Pharmacol Ther | 2018 | https://conductscience.org/library/papers/28990182 | PubMed |
| 16 | 22936313 | Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans. | Drug Metab Dispos | 2012 | https://conductscience.org/library/papers/22936313 | PubMed |
| 17 | 28599065 | The Role of the Kidney in Drug Elimination: Transport, Metabolism, and the Impact of Kidney Disease on Drug Clearance. | Clin Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28599065 | PubMed |
| 18 | 29996058 | Assessment of Transporter-Mediated and Passive Hepatic Uptake Clearance Using Rifamycin-SV as a Pan-Inhibitor of Active Uptake. | Mol Pharm | 2018 | https://conductscience.org/library/papers/29996058 | PubMed |
| 19 | 11062690 | Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats. | Anticancer Res | 2000 | https://conductscience.org/library/papers/11062690 | PubMed |
| 20 | 15762770 | Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15762770 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42771268 | Development of an isavuconazole physiologically-based pharmacokinetic model for adult and pediatric populations. | J Pharmacokinet Pharmacodyn | 2026 | https://conductscience.org/library/papers/42771268 | PubMed |
| 42652049 | Drug-Drug Interactions Between Oral Anticoagulants and Calcineurin Inhibitors in Nephrotic Syndrome for Management of Thromboembolism. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652049 | PubMed |
| 42484904 | Physiologically based pharmacokinetic (PBPK) model to predict the magnitude of drug-drug interaction between vincristine and the azole antifungals isavuconazole, posaconazole, and voriconazole in children. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42484904 | PubMed |
| 41332151 | Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans. | CPT Pharmacometrics Syst Pharmacol | 2026 | https://conductscience.org/library/papers/41332151 | PubMed |
| 41276277 | Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41276277 | PubMed |
| 40425954 | Risk Assessment for Biopharmaceutics Classification System Class IV Molecule Containing Immediate Release Products: Use of In-Silico Prediction Tools and Physiologically Based Pharmacokinetic Modeling. | AAPS J | 2025 | https://conductscience.org/library/papers/40425954 | PubMed |
| 39468637 | Abnormally high plasma concentrations of M-4, the active metabolite of edoxaban, at the onset of acute kidney injury in a patient receiving rifampin and clarithromycin: a case report. | J Pharm Health Care Sci | 2024 | https://conductscience.org/library/papers/39468637 | PubMed |
| 37101392 | Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution. | CPT Pharmacometrics Syst Pharmacol | 2023 | https://conductscience.org/library/papers/37101392 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| CECR | 1055 | PubTator's text mining | https://conductscience.org/library/genes/1055 | NCBI Gene |
| CES1 | 1066 | PubTator's text mining | https://conductscience.org/library/genes/1066 | NCBI Gene |
| CLINT1 | 9685 | PubTator's text mining | https://conductscience.org/library/genes/9685 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| F10 | 2159 | PubTator's text mining | https://conductscience.org/library/genes/2159 | NCBI Gene |
| PPIG | 9360 | PubTator's text mining | https://conductscience.org/library/genes/9360 | NCBI Gene |
| SLCO1A2 | 6579 | PubTator's text mining | https://conductscience.org/library/genes/6579 | NCBI Gene |
| SLCO1B1 | 10599 | PubTator's text mining | https://conductscience.org/library/genes/10599 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37101392
GET https://conductscience.org/api/papers/v1/37101392/references?page=2